World Orphan Drug Congress Europe 2019

From 12/11/2019 to 14/11/2019

The agenda covers the strategic and commercial aspects of bringing new treatments to the rare diseases space.

Government authorities, payers, industry and patient advocacy groups are among the delegates.

Barcelona, Spain

More information

Ask for a Free trial and get access to the latest stories

Our coverage includes:
  • Health Care
  • Market Access
  • HTA – policies & practices
  • European medicine regulations
  • Drug safety issues
  • Pricing & Reimbursement
  • International medicines agencies

If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.


an initial 10 day temporary access of APM Health Europe.